Guidelines can cut nonindicated acid-suppressing Rx in infants
(HealthDay)—Implementation of a guideline can reduce nonindicated use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) among newborns, according to a study published online Nov. 21 in Pediatrics.
Nov 22, 2017
0
0